These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9792136)

  • 1. Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH.
    Lowe FC; Dreikorn K; Borkowski A; Braeckman J; Denis L; Ferrari P; Gerber G; Levin R; Perrin P; Senge T
    Prostate; 1998 Nov; 37(3):187-93. PubMed ID: 9792136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cernilton for benign prostatic hyperplasia.
    Wilt T; Mac Donald R; Ishani A; Rutks I; Stark G
    Cochrane Database Syst Rev; 2000; (2):CD001042. PubMed ID: 10796739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WITHDRAWN: Cernilton for benign prostatic hyperplasia.
    Wilt TJ; Macdonald R; Ishani A; Rutks I; Stark G
    Cochrane Database Syst Rev; 2011 May; 2011(5):CD001042. PubMed ID: 21563128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant extracts in BPH.
    Di Silverio F; Flammia GP; Sciarra A; Caponera M; Mauro M; Buscarini M; Tavani M; D'Eramo G
    Minerva Urol Nefrol; 1993 Dec; 45(4):143-9. PubMed ID: 7517582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytotherapeutic agents in the treatment of benign prostatic hyperplasia.
    Dreikorn K
    Curr Urol Rep; 2000 Aug; 1(2):103-9. PubMed ID: 12084323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled trial to assess the efficacy and tolerability of mepartricin in the treatment of BPH.
    Denis L; Pagano F; Nonis A; Robertson C; Romano P; Boyle P
    Prostate; 1998 Dec; 37(4):246-52. PubMed ID: 9831221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Double-blind evaluation of mepartricin 150.000 U (40 mg) compared with placebo in benign prostatic hypertrophy].
    Prezioso D; Mirone V; Fabrizio F; Lotti T
    Minerva Urol Nefrol; 1996 Dec; 48(4):207-11. PubMed ID: 9005590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis.
    Ishani A; MacDonald R; Nelson D; Rutks I; Wilt TJ
    Am J Med; 2000 Dec; 109(8):654-64. PubMed ID: 11099686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia.
    Dreikorn K
    World J Urol; 2002 Apr; 19(6):426-35. PubMed ID: 12022711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review.
    Wilt TJ; Ishani A; Stark G; MacDonald R; Lau J; Mulrow C
    JAMA; 1998 Nov; 280(18):1604-9. PubMed ID: 9820264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal medications in the treatment of benign prostatic hyperplasia (BPH).
    Fagelman E; Lowe FC
    Urol Clin North Am; 2002 Feb; 29(1):23-9, vii. PubMed ID: 12109350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary and alternative medications for benign prostatic hyperplasia.
    Keehn A; Lowe FC
    Can J Urol; 2015 Oct; 22 Suppl 1():18-23. PubMed ID: 26497340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia].
    Dreikorn K; Schönhöfer PS
    Urologe A; 1995 Mar; 34(2):119-29. PubMed ID: 7538709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of Cernilton for the treatment of benign prostatic hyperplasia.
    MacDonald R; Ishani A; Rutks I; Wilt TJ
    BJU Int; 2000 May; 85(7):836-41. PubMed ID: 10792162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen suppression as a pharmacotherapeutic strategy in the medical treatment of benign prostatic hyperplasia: evidence for its efficacy from studies with mepartricin.
    Boehm S; Nirnberger G; Ferrari P
    Wien Klin Wochenschr; 1998 Dec; 110(23):817-23. PubMed ID: 10025034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R
    Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men.
    Beiraghdar F; Einollahi B; Ghadyani A; Panahi Y; Hadjiakhoondi A; Vazirian M; Salarytabar A; Darvishi B
    Pharm Biol; 2017 Dec; 55(1):1800-1805. PubMed ID: 28532232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Randomized double-blind study using mepartricin and a placebo in the therapy of benign prostatic hypertrophy].
    Miano L; Manieri C; Paradiso Galatioto G
    Minerva Urol Nefrol; 1988; 40(2 Suppl):50-2. PubMed ID: 2460952
    [No Abstract]   [Full Text] [Related]  

  • 19. [Phytotherapy of benign prostatic hyperplasia].
    Bracher F
    Urologe A; 1997 Jan; 36(1):10-7. PubMed ID: 9123676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytotherapeutic agents in the management of symptomatic benign prostatic hyperplasia.
    Fitzpatrick JM; Lynch TH
    Urol Clin North Am; 1995 May; 22(2):407-12. PubMed ID: 7539185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.